Graeme Ball is a detail-oriented professional and published researcher currently serving as the Director of Value & Access for the International Region at Gilead Sciences. With expertise in health technology assessment (HTA), market access strategy, and health economics, they have held various roles, including Senior Manager for Market Access at Gilead Sciences and Health Economics & Reimbursement Manager at Janssen Inc. Graeme has also gained experience as a Health Economist at the Programs for Assessment of Technology in Health (PATH) Research Institute and as a Consultant at IQVIA. They hold a PhD in Health Research Methodology from McMaster University, along with a MSc in Political Economy from BI Norwegian Business School and a BA in Economics from McMaster University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices